COM:ONCTERNAL
Oncternal Therapeutics
- Stock
Last Close
1.16
22/11 21:00
Market Cap
21.66M
Beta: -
Volume Today
22.02K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | -2.51M - | 785K - | ||||||||||
cost of revenue | ||||||||||||
gross profit | -2.51M - | 785K - | ||||||||||
selling and marketing expenses | ||||||||||||
general and administrative expenses | 11.28M - | 9.48M 15.98% | 8.23M 13.13% | 8.71M 5.72% | 9.19M 5.55% | 9.39M 2.20% | 7.29M 22.41% | 8.37M 14.92% | 11.60M 38.48% | 13.46M 16.06% | 12.75M 5.28% | |
selling general and administrative expenses | 11.28M - | 9.48M 15.98% | 8.23M 13.13% | 8.71M 5.72% | 9.19M 5.55% | 9.39M 2.20% | 7.29M 22.41% | 8.37M 14.92% | 11.60M 38.48% | 13.46M 16.06% | 12.75M 5.28% | |
research and development expenses | 32.32M - | 20.87M 35.42% | 13.61M 34.80% | 17.23M 26.61% | 21.47M 24.61% | 29.67M 38.21% | 10.16M 65.76% | 12.54M 23.48% | 24.09M 92.01% | 32.98M 36.93% | 29.75M 9.78% | |
other expenses | 1.49M - | -259K 117.41% | 57K 122.01% | 46K 19.30% | 216K 369.57% | 641K 196.76% | -2.42M 478.32% | -3.38M 39.18% | -4.32M 27.85% | -1.49M 65.47% | ||
cost and expenses | 43.60M - | 30.35M 30.39% | 21.84M 28.03% | 25.93M 18.74% | 30.66M 18.21% | 39.06M 27.41% | 15.02M 61.55% | 17.54M 16.79% | 31.37M 78.81% | 44.95M 43.30% | 42.50M 5.45% | |
operating expenses | 43.60M - | 30.35M 30.39% | 21.84M 28.03% | 25.93M 18.74% | 30.66M 18.21% | 39.06M 27.41% | 15.02M 61.55% | 17.54M 16.79% | 31.37M 78.81% | 44.95M 43.30% | 42.50M 5.45% | |
interest expense | -702K - | |||||||||||
ebitda | -43.60M - | -21.54M 50.59% | -24.92M 15.68% | -34.10M 36.81% | -30.66M 10.09% | -39.01M 27.26% | -14.83M 61.98% | -17.54M 18.27% | -31.37M 78.81% | -44.95M 43.30% | -41.71M 7.19% | |
operating income | -43.60M - | -30.35M 30.39% | -21.84M 28.03% | -25.93M 18.74% | -30.66M 18.21% | -39.06M 27.41% | -33.11M 15.24% | -17.54M 47.02% | -31.37M 78.81% | -44.95M 43.30% | -41.71M 7.19% | |
depreciation and amortization | 384K - | 102K 73.44% | 43K 57.84% | 28K 34.88% | 47K 67.86% | 46K 2.13% | 18.28M 39,630.43% | |||||
total other income expenses net | 1.49M - | -9.06M 709.07% | 3.14M 134.62% | 8.21M 161.60% | 216K 97.37% | 641K 196.76% | -1.08M 268.49% | 317K 129.35% | 33K 89.59% | 777K 2,254.55% | 2.23M 187.64% | |
income before tax | -42.11M - | -39.41M 6.41% | -18.70M 52.54% | -17.72M 5.23% | -30.44M 71.74% | -38.42M 26.21% | -34.19M 11.01% | -17.23M 49.62% | -31.33M 81.90% | -44.17M 40.97% | -39.48M 10.62% | |
income tax expense | -384K - | 8.70M 2,366.15% | -3.12M 135.90% | -8.19M 162.20% | -47K 99.43% | 641K 1,463.83% | -18.28M 2,951.17% | -16K 99.91% | -33K 106.25% | -777K 2,254.55% | ||
net income | -42.11M - | -39.41M 6.41% | -18.70M 52.54% | -17.72M 5.23% | -30.44M 71.74% | -38.42M 26.21% | -15.91M 58.58% | -17.21M 8.15% | -31.30M 81.88% | -43.39M 38.64% | -39.48M 9.02% | |
weighted average shs out | 900.82K - | 1.17M 29.74% | 2.01M 71.58% | 2.08M 3.73% | 2.49M 19.79% | 3.34M 33.86% | 10.33M 209.70% | 20.30M 96.58% | 49.32M 142.90% | 52.59M 6.64% | 2.94M 94.41% | |
weighted average shs out dil | 900.82K - | 1.17M 29.74% | 2.11M 80.64% | 2.08M 1.47% | 2.49M 19.79% | 3.34M 33.86% | 10.33M 209.70% | 20.30M 96.58% | 49.32M 142.90% | 52.59M 6.64% | 2.94M 94.41% | |
eps | -46.75 - | -33.72 27.87% | -9.33 72.33% | -8.52 8.68% | -12.22 43.43% | -11.52 5.73% | -1.54 86.63% | -0.85 44.81% | -0.63 25.88% | -0.83 31.75% | -13.43 1,518.07% | |
epsdiluted | -46.75 - | -33.72 27.87% | -8.86 73.72% | -8.52 3.84% | -12.22 43.43% | -11.52 5.73% | -1.54 86.63% | -0.85 44.81% | -0.63 25.88% | -0.83 31.75% | -13.43 1,518.07% |
All numbers in USD (except ratios and percentages)